Brief: MedCap Sees Q4 EBITA At SEK 71 Mln, Down 23% Vs Year Ago

MedCap AB (publ)

17/01/2025 07:48

Jan 17 (Reuters) - MedCap AB  MEDCAP.ST  :
    * SAID ON THURSDAY ESTIMATES THAT Q4 REVENUES WILL AMOUNT TO
SEK
474 MLN, UP 4 % VS YEAR AGO 
    * Q4 EBITA IS EXPECTED TO AMOUNT TO SEK 71 MLN, DOWN 23% VS
YEAR
AGO  
    * Q4 ADJUSTED EBITA IS EXPECTED TO AMOUNT TO SEK 67 MLN,
DOWN 27%
VS YEAR AGO  
    * SAID SIGNIFICANTLY LOWER EARNINGS IN BUSINESS AREA
SPECIALTY
PHARMA ARE DUE TO INCREASED COMPETITION ON BRITISH MARKET FOR
MELATONIN
    * SAID MARGIN IS IMPACTED E.G. BY PRODUCT MIX AND INVENTORY
WRITE-DOWNS

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nWkr2nk2RK
 Further company coverage:  MEDCAP.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))